医学
内科学
优势比
克罗恩病
回顾性队列研究
胃肠病学
结肠镜检查
外科
疾病
结直肠癌
癌症
作者
Samuel Raimundo Fernandes,Juliana Serrazina,Inês Ayala Botto,Tiago Leal,Andreia Guimarães,Joana Lemos Garcia,Isadora Rosa,Rita Prata,Diana Carvalho,João A. Cunha Neves,Pedro Campelo,Sofia Ventura,Andrea Silva,Mariana Coelho,Cristiana Sequeira,Ana Paula Oliveira,Francisco Portela,Paula Ministro,Helena Tavares de Sousa,Jaime Ramos
摘要
INTRODUCTION: Evidence supporting transmural remission (TR) as a long-term treatment target in Crohn's disease (CD) is still unavailable. Less stringent but more reachable targets such as isolated endoscopic (IER) or radiologic remission (IRR) may also be acceptable options in the long-term. METHODS: Multicenter retrospective study including 404 CD patients evaluated by magnetic resonance enterography and colonoscopy. Five-year rates of hospitalization, surgery, use of steroids, and treatment escalation were compared between patients with TR, IER, IRR, and no remission (NR). RESULTS: 20.8% of CD patients presented TR, 23.3% IER, 13.6% IRR and 42.3% NR. TR was associated with lower risk of hospitalization (odds-ratio [OR] 0.244 [0.111-0.538], p < 0.001), surgery (OR 0.132 [0.030-0.585], p = 0.008), steroid use (OR 0.283 [0.159-0.505], p < 0.001), and treatment escalation (OR 0.088 [0.044-0.176], p < 0.001) compared to no NR. IRR resulted in lower risk of hospitalization (OR 0.333 [0.143-0.777], p = 0.011) and treatment escalation (OR 0.260 [0.125-0.540], p < 0.001), while IER reduced the risk of steroid use (OR 0.442 [0.262-0.745], p = 0.002) and treatment escalation (OR 0.490 [0.259-0.925], p = 0.028) compared to NR. CONCLUSIONS: TR improved clinical outcomes over 5 years of follow-up in CD patients. Distinct but significant benefits were seen with IER and IRR. This suggests that both endoscopic and radiologic remission should be part of the treatment targets of CD.
科研通智能强力驱动
Strongly Powered by AbleSci AI